Press / media

As an institution of application-oriented research, the Fraunhofer Institute for Cell Therapy and Immunology IZI attaches great importance to informing customers and the public.

1.7.2026

Professor Zoltán Ivics Elected as an EMBO Member

Professor Zoltán Ivics, head of the Clinical Gene Transfer Unit at the Fraunhofer Institute for Cell Therapy and Immunology IZI, has been elected as a new member of the European Molecular Biology Organization (EMBO). This membership recognizes his outstanding contributions to molecular and cell biology.
more info

11.5.2026

Fighting cancer with superpowers: Fraunhofer IZI to feature two exhibits on CAR-T cell therapy at MS Wissenschaft 2026

The theme of Science Year 2026 is “Medicine of the Future.” At MS Wissenschaft, the floating science center touring Germany and Austria from May 7 to September 30, this year’s focus is on how researchers are already developing the medicine of tomorrow.
more info

6.5.2026

Fraunhofer IZI Spin-off PerioTrap Pharmaceuticals GmbH Awarded VORSPRUNG Business Prize

PerioTrap Pharmaceuticals GmbH received the VORSPRUNG Business Prize on May 5. The Fraunhofer IZI spin-off develops microbiome-based solutions for the prevention of gum disease.
more info

30.4.2026

Center of Excellence to engineer advanced cell therapies

Kytopen, T-CURX, and the Fraunhofer Institute for Cell Therapy and Immunology IZI establish a Center of Excellence to develop advanced, non-viral cell therapies. The Center of Excellence will serve as a hub for innovation in non-viral cell therapy development, focusing on scalable, efficient, and clinically robust manufacturing processes.
more info

Archive news and press releases

RSS Newsfeed

Get the latest news about the Fraunhofer IZI. Through our RSS-feed you have the opportunity to follow all our press releases and receive them right when they are published.

Social media

 

Media library

 

Publications

 

Events